Clinical Trial Update: Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update describing STK-012 alone or in combination for advanced lung cancer and other solid tumors, currently recruiting in Phase 1/2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer
• Solid Tumors

Drugs mentioned

• STK-012

Snippet

Sponsor: Synthekine | Conditions: Advanced Solid Tumor, Non Small Cell Lung Cancer | Phase 1, Phase 2 | Status: RECRUITING